NewLimit Secures $435 Million for Upcoming Clinical Trial of Liver Medicine
NewLimit, a longevity-focused startup, has successfully raised $435 million in funding, which will support its first clinical trial targeting liver medicine.
Legislative Actions Challenge Corporate Structure of Telehealth Services
As states increase scrutiny on corporate medicine, the telehealth sector faces significant challenges. The focus is on the corporate frameworks that support direct-to-consumer services.
New Lung Cancer Drug Shows Promise at ASCO, Calls for Broader Trials
Ivonescimab, a lung cancer treatment from China, garnered attention at ASCO for its potential to extend survival in patients with squamous cell lung cancer, though experts urge for trials involving a more diverse patient base.
Upfront Hormone Therapy Shows Promise for Prostate Cancer Surgery Patients
A new study indicates that initiating hormone therapy before surgery may lead to lower relapse rates in prostate cancer patients, suggesting a shift in treatment strategies.
Promising Advances in Pancreatic Cancer Treatment from Revolution Medicines
Recent findings presented at ASCO indicate significant progress in targeting a key component of pancreatic cancer, referred to as a 'greasy ball'.
Revolution Medicines to Submit Pancreatic Cancer Drug for FDA Approval
Mark Goldsmith, CEO of Revolution Medicines, has announced the upcoming submission of daraxonrasib for FDA approval as the company begins shipping the experimental drug.
Replimune's Drug Faces Third FDA Approval Attempt Amid Pfizer's New Deal in China
Replimune is set to make a third attempt for FDA approval of its drug, while Pfizer has recently secured a deal in China, highlighting ongoing developments in the pharmaceutical sector.
New Insights into Mitochondrial Protein Production Mechanisms
A recent study by researchers at University Medical Center Göttingen and the Max Planck Institute sheds light on the regulation of protein synthesis in mitochondria, with potential implications for understanding mitochondrial diseases.
Uncertainties Surround Trump's Pharma Agreements
Questions remain about the implications of Trump's Most Favored Nation deals with pharmaceutical companies, as scrutiny increases.
Pancreatic Cancer Takes Center Stage Ahead of ASCO
As the ASCO conference approaches, attention is drawn to pancreatic cancer developments, alongside significant biotech advancements including GSK's hepatitis B drug.
FDA Delays Decision on AstraZeneca's Breast Cancer Treatment Following Panel Vote
The FDA has postponed its decision on AstraZeneca's experimental breast cancer pill after an advisory panel voted against its approval, signaling further review is needed.
Eli Lilly's Gene Editing Therapy Shows Promise in Lowering Cholesterol
Eli Lilly has announced encouraging results from a recent clinical trial of its gene-editing therapy, indicating a significant reduction in cholesterol levels among participants.
Innovative Technique Enhances Bacterial Detection Speed and Sensitivity
Researchers at Osaka Metropolitan University have introduced a novel light-driven method that efficiently concentrates bacteria, potentially improving diagnostic capabilities.
Divergence Among EU and US Advisers on AstraZeneca's Breast Cancer Treatment
Recent discussions reveal a split between EU and US advisers regarding AstraZeneca's breast cancer drug, amid notable developments in other biotech areas.
Recent Developments in Parkinson's and Lung Cancer Therapies
Biogen and Denali's experimental treatment for Parkinson's disease has not achieved its trial objectives, while Merck's lung cancer therapy appears to offer potential benefits.
Genentech Pursues Research to Challenge Proposed Pharma Reforms
Genentech is seeking research to bolster its position against potential pharmaceutical reforms in Washington, aiming to influence policy discussions.
Challenges in Nanoparticle Drug Delivery Highlighted by New Research
Recent findings reveal significant issues with the release of drugs from nanoparticle carriers, raising concerns for the future of precision medicine.
Elevance Executive to Testify Amid Medicare Advantage Fraud Allegations
The Department of Justice has ordered an executive from Elevance to testify regarding allegations of fraudulent billing related to Medicare Advantage.
Eli Lilly's Investigational Drug Shows Potential in Diabetes Management
Eli Lilly's investigational drug, known as 'triple-G', has demonstrated significant effects on blood sugar and weight in a late-stage diabetes trial.
Interim Surgeon General Appointed as Health Department Faces Leadership Gaps
In a move to address leadership vacancies, Kennedy has appointed Stephanie Haridopolos, a family medicine physician and senior HHS adviser, as interim surgeon general.